Houlihan Lokey Advises Paradigm Oral Health

Houlihan Lokey is pleased to announce that Paradigm Oral Health (Paradigm), a portfolio company of InTandem Capital Partners (InTandem), has been acquired by Blackrock Long Term Private Capital (LTPC). The transaction closed on November 16, 2022.

Founded in 2018, Paradigm has developed an industry-leading model designed to attract and retain best-in-class surgeons focused on delivering the highest quality of oral health care and dental implant surgery while fostering a medically driven, patient-friendly culture of excellence. The company partners with leading oral surgery groups in markets across the United States, allowing them to maintain their unique brand identity while operating on the same platform. Paradigm’s proprietary practice management technology, Paragon, utilizes cutting-edge technology and data analytics to provide and store proprietary information and intelligence generated by the business, leading to enhanced performance as well as increased patient and provider satisfaction. Today, Paradigm and its team of over 100 surgeon partners provide patient care in 75 state-of-the-art facilities throughout the United States.

InTandem is a private equity firm that invests in and helps accelerate the growth of select healthcare services companies. Its goal is to build excellent businesses of significant value working collaboratively with its management team partners. InTandem comprises former business executives and experienced investors, and it is uniquely qualified to provide strategic, acquisition, and operating expertise to help companies significantly increase their value over time.

LTPC is an innovative private equity strategy focused on investing in high-quality businesses and value creation through active collaboration with management teams. The strategy's flexible duration and prudent approach to leverage preserve optionality for growth and help enable compounded capital appreciation. LTPC's team of 23 professionals are based in New York and London and invest across North America and Western Europe. LTPC is backed by Blackrock, Inc., which manages $313 billion in alternative investments and commitments on behalf of clients worldwide as of September 30, 2022.

Houlihan Lokey served as exclusive financial advisor to Paradigm and InTandem and assisted in initiating, structuring, and negotiating on their behalf.

Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2021, the group closed 43 transactions and was ranked by Refinitiv as the No. 1 M&A advisor for U.S. healthcare transactions under $1 billion. This transaction builds on Houlihan Lokey’s leading track record in the dental sector specifically, having advised on more than 50 transactions.